Nuria Lafuente-Gómez

Nuria Lafuente-Gómez

Auto-generated profile, based on publicly available information

Nuria Lafuente-Gómez

Fundacion IMDEA Nanociencia, Madrid, SPAIN

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
Juan L ParisJuan L Paris
Juan L Paris
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
VCVICTORIA CABAÑAS
VICTORIA CABAÑAS
Jesus RomanJesus Roman
Jesus Roman
JPJuan Peña
Juan Peña
María Vallet-RegíMaría Vallet-Regí
María Vallet-Regí

8 May 2024 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
DGDavid García-Soriano
David García-Soriano
PMPaula Milán
Paula Milán
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
CRCiro Rodríguez-Díaz
Ciro Rodríguez-Díaz
CNCristina Navío
Cristina Navío
GSGorka Salas
Gorka Salas

16 March 2022 in Talanta
Verified
Journal Article
Open access
CRCiro Rodríguez
Ciro Rodríguez
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
CCCatarina Coutinho
Catarina Coutinho
DPDemián Pardo
Demián Pardo
HAHernán Alarcón-Iniesta
Hernán Alarcón-Iniesta
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
We present a fast, reliable and easy to scale-up colorimetric sensor based on gold nanoparticles (AuNPs) to detect the sequences coding for the RdRp, E, and S proteins of SARS-CoV-2. The optimization of the system (so-called “the sensor”) includes the evaluation of different sizes of nanoparticles, sequences of oligonucleotides and buffers. It is stable for months without any noticeable decrease in its activity, allowing the detection of SARS-CoV-2 sequences by the naked eye in 15 min. The efficiency and selectivity of detection, in terms of significative colorimetric changes in the solution upon target recognition, are qualitatively (visually) and quantitatively (absorbance measurements) assessed using synthetic samples and samples derived from infected cells and patients. Furthermore, an easy and affordable amplification approach is implemented to increase the system's sensitivity for detecting high and medium viral loads (≥103 - 104 viral RNA copies/μl) in patient samples. The whole process (amplification and detection) takes 2.5 h. Due to the ease of use, stability and minimum equipment requirements, the proposed approach can be a valuable tool for the detection of SARS-CoV-2 at facilities with limited resources.

1 October 2020 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
DGDavid García-Soriano
David García-Soriano
RARebeca Amaro
Rebeca Amaro
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
PMPaula Milán
Paula Milán
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
GSGorka Salas
Gorka Salas

14 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
PMPaula Milán
Paula Milán
DGDavid García-Soriano
David García-Soriano
YLYurena Luengo
Yurena Luengo
Marco CordaniMarco Cordani
Marco Cordani
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
Magnetic nanoparticles (MNP) are employed as nanocarriers and in magnetic hyperthermia (MH) for the treatment of cancers. Herein, a smart drug delivery system composed of MNP functionalized with the cytotoxic drug gemcitabine (MNP-GEM) has been thoroughly evaluated. The linker employed is based on a disulfide bond and allows the controlled release of GEM under a highly reducing environment, which is frequently present in the cytoplasm of tumor cells. The stability, MH, and the interaction with plasma proteins of the nanoparticles are evaluated, highlighting their great potential for biological applications. Their cytotoxicity is assessed in three pancreatic cancer cell lines with different sensitivity to GEM, including the generation of reactive oxygen species (ROS), the effects on the cell cycle, and the mechanisms of cell death involved. Remarkably, the proposed nanocarrier is better internalized than unmodified nanoparticles, and it is particularly effective in PANC-1 cells, resistant to GEM, but not in non-tumoral keratinocytes. Additionally, its combination with MH produces a synergistic cytotoxic effect in all cancer cell lines tested. In conclusion, MNP-GEM presents a promising potential for treating pancreatic cancer, due to multiple parameters, such as reduced binding to plasma proteins, increased internalization, and synergistic activity when combined with MH.

11 January 2022 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
DGDavid García-Soriano
David García-Soriano
PMPaula Milán
Paula Milán
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
CNCristina Navío
Cristina Navío
LGLucía Gutiérrez
Lucía Gutiérrez
GSGorka Salas
Gorka Salas